Stock Market Update, Dec. 16: Tilray Brands Jumps 27.5% After Trump Hints at Possible Marijuana Reclassification
Tilray Brands (NASDAQ:TLRY), a global player in the medical cannabis sector, saw its shares rise by 27.54% on Tuesday, closing at $13.94. Trading volume peaked at 46.8 million shares, which is about 525% more than the three-month average of 8.9 million shares. This surge aligns with a broader uptick in the cannabis industry following President […]
Tilray (TLRY) Valuation under Review as U.S. Reclassification and European Growth Drive Stock Increase
If you’ve been keeping an eye on Tilray (Nasdaqgs: TLRY) lately, you might have noticed a significant surge in its stock price. This dramatic increase follows President Trump’s decision to reclassify marijuana as a Schedule III substance. Alongside this, Tilray has announced a partnership with Morteni aimed at deepening its presence in Europe, marking a […]
Charlie Kirk calls on Trump to rethink marijuana reclassification: ‘Safeguard public areas for children’
During a recent $1 million fundraiser in New Jersey, President Donald Trump mentioned he is considering changing the classification of marijuana to a Schedule III drug under the Controlled Substances Act. This potential reclassification has been confirmed by Trump himself. One of Trump’s dedicated supporters expressed optimism that the president will ultimately decide to loosen […]